Plasma epinephrine predicts fasting glucose in centrally obese African-American women

Obesity

Volumn 18, Issue 9, 2010, Pages 1683-1687

  Surwit, Richard S ^a   Williams, Redford B ^a   Lane, James D ^a   Feinglos, Mark N ^a   Kuhn, Cynthia M ^a   Georgiades, Anastasia ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ABDOMINAL OBESITY; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; BODY MASS; DIET RESTRICTION; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MENTAL STRESS; METABOLISM; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS;

ADULT; AFRICAN AMERICANS; BLOOD GLUCOSE; BODY MASS INDEX; EPINEPHRINE; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; OBESITY, ABDOMINAL; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 77956089108     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.43     Document Type: Article

References (27)

1. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racialand ethnic differences in glycemic control of adults with type 2 diabetes.Diabetes Care 1999;22:403-408.
2. Okosun IS. Racial differences in rates of type 2 diabetes in Americanwomen: how much is due to differences in overall adiposity? Ethn Health2001;6:27-34.
3. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia asrisk factors for diabetes and cardiovascular disease. Arteriosclerosis1986;6:123-130.
4. Rebuffé-Scrive M, Anderson B, Olbe L, Björntorp P. Metabolism of adiposetissue in intraabdominal depots in severely obese men and women.Metabolism 1990;39:1021-1025.
5. Surwit RS, Schneider MS, Feinglos MN. Stress and diabetes mellitus.Diabetes Care 1992;15:1413-1422.
6. Surwit RS, Schneider MS. Role of stress in the etiology and treatment ofdiabetes mellitus. Psychosom Med 1993;55:380-393.
7. Björntorp P. Visceral fat accumulation: the missing link between psychosocialfactors and cardiovascular disease J Intern Med 1991;230:195-201.
8. Surwit RS, Williams PG. Animal models provide insight into psychosomaticfactors in diabetes. Psychosom Med 1996;58:582-589.
9. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Dietinducedtype II diabetes in C57BL/6J mice. Diabetes 1988;37:1163-1167.
10. Bergman RN. Orchestration of glucose homeostasis: from a small acorn tothe California oak. Diabetes 2007;56:1489-1501.
11. Fain JN, Garcia-Sáinz JA. Adrenergic regulation of adipocyte metabolism.J Lipid Res 1983;24:945-966.
12. Bays HE, González-Campoy JM, Bray GA et al. Pathogenic potential ofadipose tissue and metabolic consequences of adipocyte hypertrophy andincreased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6:343-368.
13. Vicini P, Avogaro A, Spilker ME, Gallo A, Cobelli C. Epinephrine effects oninsulin-glucose dynamics: the labeled IVGTT two-compartment minimalmodel approach. Am J Physiol Endocrinol Metab 2002;283:E78-E84.
14. Brummett BH, Boyle SH, Kuhn CM, Siegler IC, Williams RB. Positive affect isassociated with cardiovascular reactivity, norepinephrine level, and morningrise in salivary cortisol. Psychophysiology 2009;46:862-869.
15. Kilts CD, Gooch MD, Knopes KD. Quantitation of plasma catecholaminesby on-line trace enrichment high performance liquid chromatography withelectrochemical detection. J Neurosci Methods 1984;11:257-273.
16. Bergman RN, Kim SP, Hsu IR et al. Abdominal obesity: role in thepathophysiology of metabolic disease and cardiovascular risk. Am JMed 2007;120:S3-8; discussion S29.
17. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk oftype 2 diabetes diagnosis. Am J Med 2008;121:519-524.
18. de Glisezinski I, Larrouy D, Bajzova M et al. Adrenaline but not noradrenalineis a determinant of exercise-induced lipid mobilization in humansubcutaneous adipose tissue. J Physiol (Lond) 2009;587:3393-3404.
19. Surwit RS, Lane JD, Millington DS et al. Hostility and minimal modelof glucose kinetics in African American women. Psychosom Med2009;71:646-651.
20. Penev P, Spiegel K, Marcinkowski T, Van Cauter E. Impact of carbohydraterichmeals on plasma epinephrine levels: dysregulation with aging. J ClinEndocrinol Metab 2005;90:6198-6206.
21. Duez H, Lewis GF. Fat metabolism in insulin resistance and type 2 diabetes.In: Feinglos MN, Bethel MA (eds). Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management, vol.1. Humana: Durham, NC,2008, pp 49-73.
22. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2diabetes mellitus in African American and white adults: the AtherosclerosisRisk in Communities Study. JAMA 2000;283:2253-2259.
23. McConnaughey MM, Sheets KA, Davis J et al. Differences in betaadrenergicreceptor densities in omental and subcutaneous adiposetissue from obese African American and Caucasian women. Metabolism2004;53:247-251.
24. Jensen MD. Adipose tissue and fatty acid metabolism in humans. J R SocMed 2002;95 Suppl 42:3-7.
25. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fatdistribution and metabolic risk factors: effects of race. Metabolism1996;45:1119-1124.
26. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity,insulin secretion, and abdominal fat: the Insulin Resistance AtherosclerosisStudy (IRAS) Family Study. Diabetes 2003;52:2490-2496.
27. Surwit RS, Feinglos MN. Stress and autonomic nervous system in type IIdiabetes. A hypothesis. Diabetes Care 1988;11:83-85.